Foundation Medicine (FMI) Misses Q2 EPS by 1c

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.39 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
• Corteva Inc. (CTVA) PT Lowered to $85 at UBS Amid High Expectations
• H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)